½ÃÀ庸°í¼­
»óǰÄÚµå
1384827

¼¼°èÀÇ °í¾Ð»ê¼Ò¿ä¹ý ±â±â ½ÃÀå ±Ô¸ð, Á¡À¯À², »ê¾÷ µ¿Ç⠺м® ¸®Æ÷Æ® : ¿ëµµº°, Á¦Ç°º°, Áö¿ªº° Àü¸Á°ú ¿¹Ãø(2023-2030³â)

Global Hyperbaric Oxygen Therapy Devices Market Size, Share & Industry Trends Analysis Report By Application, By Product, By Regional Outlook and Forecast, 2023 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: KBV Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 277 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

°í¾Ð»ê¼Ò¿ä¹ý ±â±â ½ÃÀå ±Ô¸ð´Â ¿¹Ãø ±â°£ Áß CAGR 5.1%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 47¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. 2022³â ½ÃÀå ±Ô¸ð´Â 1,13,114´ë·Î, ¼ºÀå·üÀº 4.9%¿¡ ´ÞÇϰí ÀÖ½À´Ï´Ù.(2019-2022³â)

±×·¯³ª, ¾Ð·Â º¯È­·Î ÀÎÇÑ »óó´Â ¾Ð·Â º¯È­·Î ÀÎÇÑ »óó¸¦ ÀǹÌÇϸç, HBOT Áß ¾Ð·Â º¯È­´Â ±Í, ºÎºñµ¿, Æó¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. ȯÀÚ´Â ±Í ÅëÁõ, ºÎºñµ¿ È¥Àâ, Æó ¼Õ»óÀ» °æÇèÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ À§ÇèÀ» ÁÙÀ̱â À§ÇØ È¯ÀÚ¸¦ ½ÅÁßÇÏ°Ô ¼±º°ÇÏ°í ¾ÈÀü Á¶Ä¡¸¦ ÃëÇÏÁö¸¸, ÀϺΠȯÀÚ´Â ¾Ð·Â ¿Ü»ó °¡´É¼º ¶§¹®¿¡ HBOT¸¦ ¹ÞÁö ¾ÊÀ¸·Á´Â »ç¶÷µµ ÀÖ½À´Ï´Ù. °í³óµµ »ê¼Ò¿¡ Àå½Ã°£ ³ëÃâµÇ¸é »ê¼Ò Áßµ¶À» ÀÏÀ¸ÄÑ Æó¿Í ÁßÃ߽Űæ°è ¹®Á¦¸¦ À¯¹ßÇÒ ¼ö ÀÖÀ¸¸ç, HBOT ¼¼¼ÇÀº »ê¼Ò Áßµ¶ÀÇ À§ÇèÀ» ÃÖ¼ÒÈ­Çϱâ À§ÇØ ÁÖÀÇ ±í°Ô ¸ð´ÏÅ͸µµË´Ï´Ù. °æ¿ì¿¡ µû¶ó °Ç°­ º¸ÇèÀÌ HBOT¸¦ º¸ÀåÇÏÁö ¾ÊÀ» ¼ö ÀÖÀ¸¸ç, Àڱ⠺δã±ÝÀ» ÁöºÒÇÒ ¼ö ¾ø´Â ȯÀÚµéÀº HBOT¸¦ ÀÌ¿ëÇÏ±â ¾î·Æ°í, HBOT¿Í ±× À§Çè¿¡ ´ëÇÑ À߸øµÈ Á¤º¸¿Í ¿ÀÇØ°¡ ÀáÀçÀûÀΠȯÀÚµéÀÇ ¹ß¸ñÀ» ÀâÀ» ¼öµµ ÀÖ½À´Ï´Ù. À§ÀÇ Ãø¸éÀº ½ÃÀå ¼ºÀå¿¡ ¹æÇذ¡ µÉ ¼ö ÀÖ½À´Ï´Ù.

COVID-19´Â °í¾Ð»ê¼ÒÄ¡·á±â ½ÃÀå¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ´Ù¸¥ ¸¹Àº »ê¾÷°ú ¸¶Âù°¡Áö·Î Àü¿°º´ÀÇ Ãʱ⠴ܰ迡¼­ HBOT Àåºñ¸¦ Æ÷ÇÔÇÑ ÀÇ·á±â±âÀÇ Á¦Á¶ ¹× °ø±Þ¸ÁÀº È¥¶õÀ» °Þ¾ú½À´Ï´Ù. Àá±Ý, À̵¿ Á¦ÇÑ ¹× °ø±Þ¸Á Áß´ÜÀº ÀÌ·¯ÇÑ ÀåºñÀÇ »ý»ê ¹× À¯Åë¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ÀÌ·Î ÀÎÇØ ´çÀå »ý¸íÀ» À§ÇùÇÏ´Â °ÍÀ¸·Î °£ÁÖµÇÁö ¾Ê´Â Áõ»ó¿¡ ´ëÇÑ HBOT ±â±âÀÇ »ç¿ëÀÌ ÀϽÃÀûÀ¸·Î °¨¼ÒÇßÀ¸¸ç, COVID-19 °ü·Ã ÇÕº´Áõ Ä¡·á¿¡ ´ëÇÑ HBOTÀÇ È¿´ÉÀ» ޱ¸ÇÏ´Â ÀÓ»ó½ÃÇè°ú ¿¬±¸°¡ ½ÃÀ۵Ǿú½À´Ï´Ù. ±×·¯³ª ½ÃÀåÀº ÆÒµ¥¹Í ÀÌÈÄ ºü¸£°Ô ȸº¹µÇ¾î ÇâÈÄ ¼ö³â°£ Å©°Ô È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿ëµµº° Àü¸Á

¿ëµµ¿¡ µû¶ó ½ÃÀåÀº »óó Ä¡À¯, °¨¾ÐÁõ, °¨¿° Ä¡·á, °¡½º »öÀüÁõ ¹× ±âŸ·Î ¼¼ºÐÈ­µË´Ï´Ù. °¨¾ÐÁõ ºÐ¾ß´Â 2022³â ½ÃÀå¿¡¼­ Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, HBOT´Â 'Àá¼öº´'À¸·Îµµ ¾Ë·ÁÁø °¨¾ÐÁõ(DCS)¿¡ ´ëÇÑ ¸Å¿ì È¿°úÀûÀÎ Ä¡·á¹ýÀÔ´Ï´Ù. °¨¾ÐÁõÀº ½ºÄí¹ö ´ÙÀ̹ö³ª ¼öÁß ÀÛ¾÷ÀÚ°¡ °í¾Ð ȯ°æ(¼öÁß µî)¿¡¼­ Àú¾Ð ȯ°æ(¼ö¸é)À¸·Î ³Ê¹« ºü¸£°Ô »ó½ÂÇÒ ¶§ ¹ß»ýÇÕ´Ï´Ù. ÀÌ ±Þ°ÝÇÑ ¾Ð·Â º¯È­·Î ÀÎÇØ ü³» Á¶Á÷°ú Ç÷·ù¿¡ Áú¼Ò ±âÆ÷°¡ ¹ß»ýÇÏ¿© °üÀýÅë, ÈäÅë, È£Èí°ï¶õ, ½Å°æÁõ»ó µî ´Ù¾çÇÑ Áõ»óÀ» À¯¹ßÇÕ´Ï´Ù.

Á¦Ç° Àü¸Á

Á¦Ç°º°·Î´Â ¸ð³ëÇ÷¹À̽º, ¸ÖƼÇ÷¹À̽º, ±¹¼ÒÇü µîÀ¸·Î ±¸ºÐµÇ¸ç, 2022³â¿¡´Â ¸ð³ëÇ÷¹À̽º ºÎ¹®ÀÌ °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¸ð³ëÇ÷¹À̽º ½Ã½ºÅÛÀº »ç¿ëÀÌ Æí¸®ÇÏ°í º´¿ø¿¡ ÃÖ¼ÒÇÑÀÇ °¡½º °ø±ÞÀÌ ÇÊ¿äÇϱ⠶§¹®¿¡ äÅ÷üÀÌ ³ô°í »ó¾÷Àû Ȱ¿ëµµ°¡ ³ô¾Æ ½ÃÀå Á¡À¯À² È®´ëÀÇ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. °¡Àå ³Î¸® »ç¿ëµÇ´Â °í¾Ðè¹ö´Â ETCÀÇ BARA-MED, BARA-MEDXD, BARA-MED Select, Pan-America Hyperbarics, Inc.ÀÇ PAH-S1-3800 °í¾Ðè¹ö¿Í PAH-S1 °í¾Ðè¹ö°¡ ÀÖ½À´Ï´Ù.

Áö¿ªº° Àü¸Á

Áö¿ªº°·Î´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, LAMEA·Î ½ÃÀåÀ» ºÐ¼®ÇßÀ¸¸ç, 2022³â¿¡´Â ºÏ¹Ì°¡ ½ÃÀå¿¡¼­ °¡Àå ³ôÀº ¸ÅÃâ Á¡À¯À²À» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀÇ Àα¸ Áõ°¡·Î ÀÎÇØ °í¾Ð »ê¼Ò Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä¿Í »óó ȸº¹ Ä¡·áÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. 2023³â 2¿ù, ¹Ì±¹ ¸¶¿ìÀÌ ¸Þ¸ð¸®¾ó ¸ÞµðÄà ¼¾ÅÍ´Â Ä¡À¯µÇÁö ¾Ê´Â »óó¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ Á¢±Ù ¹æ½ÄÀ» Á¦°øÇÏ´Â °í¾Ð »ê¼Ò Ä¡·á¸¦ °®Ãá »óó Ä¡·á Ŭ¸®´ÐÀ» °³¼³Çß½À´Ï´Ù.¸¦ °³¼³Çß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ½ÃÀå ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • ½ÃÀåÀÇ Á¤ÀÇ
  • ¸ñÀû
  • ½ÃÀå ¹üÀ§
  • ¼¼ºÐÈ­
  • Á¶»ç ¹æ¹ý

Á¦2Àå ½ÃÀåÀÇ °³¿ä

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®

Á¦3Àå ½ÃÀå °³¿ä

  • ¼­·Ð
    • °³¿ä
      • ½ÃÀå ±¸¼º°ú ½Ã³ª¸®¿À
  • ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎ
    • ½ÃÀå ÃËÁø¿äÀÎ
    • ½ÃÀå ¾ïÁ¦¿äÀÎ
  • Porter's Five Forces ºÐ¼®

Á¦4Àå ¼¼°èÀÇ °í¾Ð»ê¼Ò¿ä¹ý ±â±â ½ÃÀå : ¿ëµµº°

  • ¼¼°èÀÇ Ã¢»ó Ä¡À¯ ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ °¨¾ÐÁõ ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ °¨¿°Áõ Ä¡·á ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ °¡½º »öÀüÁõ ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ ±âŸ ½ÃÀå : Áö¿ªº°

Á¦5Àå ¼¼°èÀÇ °í¾Ð»ê¼Ò¿ä¹ý ±â±â ½ÃÀå : Á¦Ç°º°

  • ¼¼°èÀÇ ¸ð³ëÇ÷¹À̽º ½ÃÀå : Áö¿ªº°
  • ¼¼°è ¸ÖƼÇ÷¹À̽º ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ ±¹ºÎ ½ÃÀå : Áö¿ªº°

Á¦6Àå ¼¼°èÀÇ °í¾Ð»ê¼Ò¿ä¹ý ±â±â ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì ½ÃÀå
  • À¯·´ ½ÃÀå
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå
  • ¶óƾ¾Æ¸Þ¸®Ä«¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦7Àå ±â¾÷ °³¿ä

  • Fink Engineering Pty Ltd
  • Environmental Tectonics Corporation
  • HAUX-LIFE-SUPPORT GmbH
  • Gulf Coast Hyperbarics, Inc
  • HearMEC Co, Ltd.
  • Hyperbaric SAC
  • Sechrist Industries, Inc
  • SOS Group GBR Ltd
  • Perry Baromedical Corporation
  • SMP Ltd

Á¦8Àå ½ÃÀåÀÇ ¼º°ø Çʼö Á¶°Ç

KSA 23.12.04

The Global Hyperbaric Oxygen Therapy Devices Market size is expected to reach $4.7 billion by 2030, rising at a market growth of 5.1% CAGR during the forecast period. In the year 2022, the market attained a volume of 1,13,114 units, experiencing a growth of 4.9% (2019-2022).

HBOT can be used as an adjunctive treatment for certain infections, particularly those caused by anaerobic bacteria or those that benefit from increased oxygen levels to enhance the body's natural defense mechanisms. Consequently, the infection treatment segment experienced $351.9 million revenue in the market in 2022. Anaerobic bacteria are microorganisms that thrive in low-oxygen environments. HBOT exposes the body to high oxygen concentrations, creating an oxygen-rich environment inhospitable to many anaerobic pathogens. This inhibits the growth and replication of these bacteria. HBOT is administered in specialized hyperbaric chambers under the supervision of trained medical personnel. Some of the factors impacting the market are growing demand for next generation multiplace chambers, rising prevalence of chronic diseases and side effects and complications associated with HBOT.

Next generation multiplace chambers are designed with a focus on patient comfort. They often offer more spacious interiors with better seating arrangements, lighting, and entertainment options. Enhanced comfort can encourage patients to undergo longer and more effective HBOT sessions. Multiplace chambers can accommodate multiple patients simultaneously, making them a more cost-effective and efficient option for healthcare facilities. This increased capacity can reduce waiting times for patients and improve accessibility to HBOT therapy. The rising number of chronic diseases has significantly driven the hyperbaric oxygen therapy devices market growth. Chronic diseases are long-term medical conditions that often require ongoing treatment and care. HBOT has proven effective in managing and treating various chronic diseases and associated complications, increasing adoption. Diabetes is an ordinary chronic disease that can lead to difficulties such as diabetic foot ulcers. HBOT is a recognized treatment for diabetic foot ulcers, as it promotes wound healing and reduces the risk of amputation. Therefore, as healthcare providers and patients recognize the advantages of HBOT in managing and improving the quality of life for those with chronic diseases, the market for hyperbaric oxygen therapy devices is expected to continue to rise.

However, Barotrauma refers to wounds caused by changes in pressure. During HBOT, changes in pressure can affect the ears, sinuses, and lungs. Patients may experience ear pain, sinus congestion, or lung injuries. In order to mitigate this risk, patients are carefully screened, and safety measures are put in place, but the potential for barotrauma can deter some individuals from seeking HBOT. Prolonged exposure to high oxygen levels can lead to oxygen toxicity, which can cause lung and central nervous system problems. HBOT sessions are carefully monitored to minimize the risk of oxygen toxicity. In some circumstances, health insurance may not cover HBOT, making it less accessible to patients who cannot afford the out-of-pocket costs. Misinformation or misconceptions about HBOT and its risks can deter potential patients. The abovementioned aspects will hamper the market growth.

COVID-19 had a negative impact on the hyperbaric oxygen therapy devices market. Like many other industries, the manufacturing and supply chain for medical devices, including HBOT devices, were disrupted during the early stages of the pandemic. Lockdowns, restrictions on movement, and supply chain interruptions affected the production and distribution of these devices. This led to a temporary decline in the use of HBOT devices for conditions that were not considered immediately life-threatening. Clinical trials and studies exploring the efficacy of HBOT in treating COVID-19-related complications were initiated. However, the market witnessed a speedy recovery after the pandemic and will expand significantly in the coming years.

Application Outlook

Based on application, the market is fragmented into wound healing, decompression sickness, infection treatment, gas embolism, and others. The decompression sickness segment garnered a significant revenue share in the market in 2022. HBOT is a highly effective treatment for decompression sickness (DCS), also known as "the bends." DCS occurs when a scuba diver or underwater worker ascends too quickly from a high-pressure environment (such as underwater) to a lower-pressure environment (the surface). This rapid change in pressure can cause nitrogen bubbles in the body's tissues and bloodstream, leading to various symptoms, including joint pain, chest pain, breathing difficulties, and neurological symptoms.

Product Outlook

On the basis of product, the market is segmented into monoplace, multiplace, and topical. In 2022, the monoplace segment dominated the market with the maximum revenue share. The substantial adoption rate and commercial accessibility of monoplace systems, due to their user-friendliness and minimal need for hospital gas supply, are significant contributors to its larger market share. The most popular hyperbaric chambers are BARA-MED, BARA-MEDXD, and BARA-MED Select by ETC; PAH-S1-3800 Hyperbaric Chamber and PAH-S1 Hyperbaric Chamber by Pan-America Hyperbarics, Inc.

Regional Outlook

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region registered the highest revenue share in the market. The region's growing population has fueled the region's demand for hyperbaric oxygen therapy and the need for wound recovery treatment. Consumers' increasing disposable income has prompted them to seek technologically advanced medical treatments and therapies. In February of 2023, the Maui Memorial Medical Center in the United States opened a wound care clinic with hyperbaric oxygen therapy, which provides a comprehensive approach to non-healing wounds.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Fink Engineering Pty Ltd, Environmental Tectonics Corporation, HAUX-LIFE-SUPPORT GmbH, Gulf Coast Hyperbarics, Inc., HearMEC Co., Ltd., Hyperbaric SAC, Sechrist Industries, Inc, SOS Group GBR Ltd., Perry Baromedical Corporation and SMP Ltd.

Scope of the Study

Market Segments covered in the Report:

By Application (Volume, Unit, USD Million, 2019-30)

  • Wound Healing
  • Decompression Sickness
  • Infection Treatment
  • Gas Embolism
  • Others

By Product (Volume, Unit, USD Million, 2019-30)

  • Monoplace
  • Multiplace
  • Topical

By Geography (Volume, Unit, USD Million, 2019-30)

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Fink Engineering Pty Ltd
  • Environmental Tectonics Corporation
  • HAUX-LIFE-SUPPORT GmbH
  • Gulf Coast Hyperbarics, Inc.
  • HearMEC Co., Ltd.
  • Hyperbaric SAC
  • Sechrist Industries, Inc
  • SOS Group GBR Ltd
  • Perry Baromedical Corporation
  • SMP Ltd.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Hyperbaric Oxygen Therapy Devices Market, by Application
    • 1.4.2 Global Hyperbaric Oxygen Therapy Devices Market, by Product
    • 1.4.3 Global Hyperbaric Oxygen Therapy Devices Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market At a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
  • 3.3 Porter's Five Forces Analysis

Chapter 4. Global Hyperbaric Oxygen Therapy Devices Market, by Application

  • 4.1 Global Wound Healing Market, by Region
  • 4.2 Global Decompression Sickness Market, by Region
  • 4.3 Global Infection Treatment Market, by Region
  • 4.4 Global Gas Embolism Market, by Region
  • 4.5 Global Others Market, by Region

Chapter 5. Global Hyperbaric Oxygen Therapy Devices Market, by Product

  • 5.1 Global Monoplace Market, by Region
  • 5.2 Global Multiplace Market, by Region
  • 5.3 Global Topical Market, by Region

Chapter 6. Global Hyperbaric Oxygen Therapy Devices Market, by Region

  • 6.1 North America Hyperbaric Oxygen Therapy Devices Market
    • 6.1.1 North America Hyperbaric Oxygen Therapy Devices Market, by Application
      • 6.1.1.1 North America Wound Healing Market, by Country
      • 6.1.1.2 North America Decompression Sickness Market, by Country
      • 6.1.1.3 North America Infection Treatment Market, by Country
      • 6.1.1.4 North America Gas Embolism Market, by Country
      • 6.1.1.5 North America Others Market, by Country
    • 6.1.2 North America Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.1.2.1 North America Monoplace Market, by Country
      • 6.1.2.2 North America Multiplace Market, by Country
      • 6.1.2.3 North America Topical Market, by Country
    • 6.1.3 North America Hyperbaric Oxygen Therapy Devices Market, by Country
      • 6.1.3.1 US Hyperbaric Oxygen Therapy Devices Market
        • 6.1.3.1.1 US Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.1.3.1.2 US Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.1.3.2 Canada Hyperbaric Oxygen Therapy Devices Market
        • 6.1.3.2.1 Canada Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.1.3.2.2 Canada Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.1.3.3 Mexico Hyperbaric Oxygen Therapy Devices Market
        • 6.1.3.3.1 Mexico Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.1.3.3.2 Mexico Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.1.3.4 Rest of North America Hyperbaric Oxygen Therapy Devices Market
        • 6.1.3.4.1 Rest of North America Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.1.3.4.2 Rest of North America Hyperbaric Oxygen Therapy Devices Market, by Product
  • 6.2 Europe Hyperbaric Oxygen Therapy Devices Market
    • 6.2.1 Europe Hyperbaric Oxygen Therapy Devices Market, by Application
      • 6.2.1.1 Europe Wound Healing Market, by Country
      • 6.2.1.2 Europe Decompression Sickness Market, by Country
      • 6.2.1.3 Europe Infection Treatment Market, by Country
      • 6.2.1.4 Europe Gas Embolism Market, by Country
      • 6.2.1.5 Europe Others Market, by Country
    • 6.2.2 Europe Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.2.2.1 Europe Monoplace Market, by Country
      • 6.2.2.2 Europe Multiplace Market, by Country
      • 6.2.2.3 Europe Topical Market, by Country
    • 6.2.3 Europe Hyperbaric Oxygen Therapy Devices Market, by Country
      • 6.2.3.1 Germany Hyperbaric Oxygen Therapy Devices Market
        • 6.2.3.1.1 Germany Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.2.3.1.2 Germany Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.2.3.2 UK Hyperbaric Oxygen Therapy Devices Market
        • 6.2.3.2.1 UK Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.2.3.2.2 UK Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.2.3.3 France Hyperbaric Oxygen Therapy Devices Market
        • 6.2.3.3.1 France Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.2.3.3.2 France Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.2.3.4 Russia Hyperbaric Oxygen Therapy Devices Market
        • 6.2.3.4.1 Russia Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.2.3.4.2 Russia Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.2.3.5 Spain Hyperbaric Oxygen Therapy Devices Market
        • 6.2.3.5.1 Spain Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.2.3.5.2 Spain Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.2.3.6 Italy Hyperbaric Oxygen Therapy Devices Market
        • 6.2.3.6.1 Italy Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.2.3.6.2 Italy Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.2.3.7 Rest of Europe Hyperbaric Oxygen Therapy Devices Market
        • 6.2.3.7.1 Rest of Europe Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.2.3.7.2 Rest of Europe Hyperbaric Oxygen Therapy Devices Market, by Product
  • 6.3 Asia Pacific Hyperbaric Oxygen Therapy Devices Market
    • 6.3.1 Asia Pacific Hyperbaric Oxygen Therapy Devices Market, by Application
      • 6.3.1.1 Asia Pacific Wound Healing Market, by Country
      • 6.3.1.2 Asia Pacific Decompression Sickness Market, by Country
      • 6.3.1.3 Asia Pacific Infection Treatment Market, by Country
      • 6.3.1.4 Asia Pacific Gas Embolism Market, by Country
      • 6.3.1.5 Asia Pacific Others Market, by Country
    • 6.3.2 Asia Pacific Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.3.2.1 Asia Pacific Monoplace Market, by Country
      • 6.3.2.2 Asia Pacific Multiplace Market, by Country
      • 6.3.2.3 Asia Pacific Topical Market, by Country
    • 6.3.3 Asia Pacific Hyperbaric Oxygen Therapy Devices Market, by Country
      • 6.3.3.1 China Hyperbaric Oxygen Therapy Devices Market
        • 6.3.3.1.1 China Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.3.3.1.2 China Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.3.3.2 Japan Hyperbaric Oxygen Therapy Devices Market
        • 6.3.3.2.1 Japan Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.3.3.2.2 Japan Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.3.3.3 India Hyperbaric Oxygen Therapy Devices Market
        • 6.3.3.3.1 India Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.3.3.3.2 India Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.3.3.4 South Korea Hyperbaric Oxygen Therapy Devices Market
        • 6.3.3.4.1 South Korea Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.3.3.4.2 South Korea Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.3.3.5 Singapore Hyperbaric Oxygen Therapy Devices Market
        • 6.3.3.5.1 Singapore Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.3.3.5.2 Singapore Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.3.3.6 Malaysia Hyperbaric Oxygen Therapy Devices Market
        • 6.3.3.6.1 Malaysia Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.3.3.6.2 Malaysia Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.3.3.7 Rest of Asia Pacific Hyperbaric Oxygen Therapy Devices Market
        • 6.3.3.7.1 Rest of Asia Pacific Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.3.3.7.2 Rest of Asia Pacific Hyperbaric Oxygen Therapy Devices Market, by Product
  • 6.4 LAMEA Hyperbaric Oxygen Therapy Devices Market
    • 6.4.1 LAMEA Hyperbaric Oxygen Therapy Devices Market, by Application
      • 6.4.1.1 LAMEA Wound Healing Market, by Country
      • 6.4.1.2 LAMEA Decompression Sickness Market, by Country
      • 6.4.1.3 LAMEA Infection Treatment Market, by Country
      • 6.4.1.4 LAMEA Gas Embolism Market, by Country
      • 6.4.1.5 LAMEA Others Market, by Country
    • 6.4.2 LAMEA Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.4.2.1 LAMEA Monoplace Market, by Country
      • 6.4.2.2 LAMEA Multiplace Market, by Country
      • 6.4.2.3 LAMEA Topical Market, by Country
    • 6.4.3 LAMEA Hyperbaric Oxygen Therapy Devices Market, by Country
      • 6.4.3.1 Brazil Hyperbaric Oxygen Therapy Devices Market
        • 6.4.3.1.1 Brazil Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.4.3.1.2 Brazil Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.4.3.2 Argentina Hyperbaric Oxygen Therapy Devices Market
        • 6.4.3.2.1 Argentina Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.4.3.2.2 Argentina Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.4.3.3 UAE Hyperbaric Oxygen Therapy Devices Market
        • 6.4.3.3.1 UAE Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.4.3.3.2 UAE Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.4.3.4 Saudi Arabia Hyperbaric Oxygen Therapy Devices Market
        • 6.4.3.4.1 Saudi Arabia Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.4.3.4.2 Saudi Arabia Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.4.3.5 South Africa Hyperbaric Oxygen Therapy Devices Market
        • 6.4.3.5.1 South Africa Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.4.3.5.2 South Africa Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.4.3.6 Nigeria Hyperbaric Oxygen Therapy Devices Market
        • 6.4.3.6.1 Nigeria Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.4.3.6.2 Nigeria Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.4.3.7 Rest of LAMEA Hyperbaric Oxygen Therapy Devices Market
        • 6.4.3.7.1 Rest of LAMEA Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.4.3.7.2 Rest of LAMEA Hyperbaric Oxygen Therapy Devices Market, by Product

Chapter 7. Company Profiles

  • 7.1 Fink Engineering Pty Ltd.
    • 7.1.1 Company Overview
    • 7.1.2 SWOT Analysis
  • 7.2 Environmental Tectonics Corporation
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Segmental and Regional Analysis
    • 7.2.4 Research & Development Expenses
    • 7.2.5 SWOT Analysis
  • 7.3 HAUX-LIFE-SUPPORT GmbH
    • 7.3.1 Company Overview
    • 7.3.2 SWOT Analysis
  • 7.4 Gulf Coast Hyperbarics, Inc.
    • 7.4.1 Company Overview
    • 7.4.2 SWOT Analysis
  • 7.5 HearMEC Co., Ltd.
    • 7.5.1 Company Overview
    • 7.5.2 SWOT Analysis
  • 7.6 Hyperbaric SAC
    • 7.6.1 Company Overview
    • 7.6.2 SWOT Analysis
  • 7.7 Sechrist Industries, Inc.
    • 7.7.1 Company Overview
    • 7.7.2 SWOT Analysis
  • 7.8 SOS Group GBR Ltd
    • 7.8.1 Company Overview
    • 7.8.2 SWOT Analysis
  • 7.9 Perry Baromedical Corporation
    • 7.9.1 Company Overview
    • 7.9.2 SWOT Analysis
  • 7.10. SMP Ltd.
    • 7.10.1 Company Overview
    • 7.10.2 Recent strategies and developments:
      • 7.10.2.1 Partnerships, Collaborations, and Agreements:
    • 7.10.3 SWOT Analysis

Chapter 8. Winning Imperatives of Hyperbaric Oxygen Therapy Devices Market

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦